News
Should You Retire in New Mexico?
If you love green chile and Georgia O'Keeffe, and you're thinking of relocating for retirement, consider the lovely state of New Mexico. It offers a lot of natural beauty and opportunities for
The Smartest Dividend Stocks to Buy With $10,000 Right Now
How should you invest if you've just received a quick windfall? Say $10,000 or even $100,000. The stock market is near all-time highs, so an aggressive investment stance will likely expose you to a
Stevanato Group, Gerresheimer and SCHOTT Pharma, Announce Strategic Industry “Alliance for RTU”
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries
EQS-News: Gerresheimer, Stevanato Group and SCHOTT Pharma Announce Strategic Industry “Alliance for RTU”
Why Masimo Stock Crushed the Market Today
Medical tech company Masimo (NASDAQ: MASI) had some significant C-suite news to report on Wednesday, and investors clearly welcomed this. They collectively pushed the company's stock up by 6% across
DexCom Is Great. Here's Why You Shouldn't Buy It.
DexCom (NASDAQ: DXCM) is not a stock that investors should be rushing to sell. It has a few different opportunities to continue pursuing to generate growth, it has plenty of recurring revenue, and
Is DexCom a Millionaire Maker?
With the company's market cap of $28 billion today, it's important to recognize that DexCom (NASDAQ: DXCM) is already one of the world's biggest medical device manufacturers. It therefore isn't
Are CVS Health, Cigna, and UnitedHealth Group Stocks Bad News Buys With the FTC's PBM Crackdown?
Big pharmacy benefit managers (PBMs), Uncle Sam wants you. And not in a good way.
The Federal Trade Commission (FTC) announced on Sept. 20 that it filed a lawsuit against the three biggest PBMs in
Dexcom, Beyond Type 2 and Retta Establish National Glucose Awareness Week to Close the Glucose Knowledge Gap
DexCom, Inc. (NASDAQ:DXCM), the global leader in real-time continuous glucose monitoring for people with diabetes, in partnership with the nonprofit Beyond Type 2, are teaming up with author
Agilent Completes Acquisition of BIOVECTRA
Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO) that
AEVIS VICTORIA SA – Publication of Half-Year Report 2024 – Revenue up 8.0% to CHF 527.6 million – Operating profit at EBITDAR level up 21.3% to CHF 87.7 million
Why Penumbra Stock Zoomed Nearly 5% Higher Today
Veteran medical device maker Penumbra (NYSE: PEN) got a shot of good news on Wednesday. An analyst initiated coverage of the company's stock with a rather bullish review, and investors took this to
Why ResMed Stock Tumbled by 5% Today
Healthcare technology company ResMed's (NYSE: RMD) stock wasn't quite the picture of health on Wednesday. The shares lost more than 5% of their value on news of an analyst's downgrade and his new
Dexcom Brings Mentorship to Centerfield, Welcomes New, Star Athletes to Its Ground-breaking NIL Program Dexcom U
DexCom, Inc. (NASDAQ: DXCM), the global leader in real-time continuous glucose monitoring (CGM) for people with diabetes, announced today the launch of the third season of Dexcom U, the company’s
EQS-News: Gerresheimer: EcoVadis Gold with further improved score
2 Unstoppable Healthcare Stocks to Buy Right Now for Less Than $200
With $200, one can afford many lottery tickets, one of which could be a winner. However, the odds of winning meaningful money by playing the lottery are minuscule. Investing in the stock market
3 Reasons DexCom Looks Like a No-Brainer Buy Right Now
DexCom (NASDAQ: DXCM) is a big name in diabetes care. Its continuous glucose monitors (CGMs) help people track their blood glucose levels.
But the stock has been performing poorly this year amid
3 Reasons Medtronic's Stock Can Continue Rallying Higher
Medtronic (NYSE: MDT) hasn't been a terribly hot stock to own in recent years. Since 2021, its shares have declined by more than 20%. But recently, investors do appear to have been giving the stock
3 Dividend Growth Stocks That Raised Their Payouts by 400%-Plus in 10 Years
A dividend yield offers some insight into how a stock will perform. However, investors who rely solely on the yield to determine a stock's worthiness for investment can miss out on some great
QuidelOrtho Appoints Lee Bowman as Chief Human Resources Officer
QuidelOrtho Corporation (Nasdaq: QDEL) is pleased to announce the appointment of Lee Bowman as Chief Human Resources Officer (CHRO). In this pivotal role, Bowman leads QuidelOrtho’s human resources
3 Reasons UnitedHealth Group Is One of the Best Dividend Stocks You Can Own
Are you looking for a good dividend stock to own? You might want to take a closer look at UnitedHealth Group (NYSE: UNH). It's a top healthcare company to invest in, and while its yield may not look
Why QuidelOrtho Stock Blasted 10% Higher Today
Sometimes, all a stock needs to have a good day on Wall Street is a positive note from one of the analysts tracking it. This dynamic was in evidence on Thursday with QuidelOrtho (NASDAQ: QDEL), when
Billionaire Ray Dalio's Former Hedge Fund Is Buying These 3 Top Dividend Stocks. Should You?
Savvy investors often look to billionaire portfolios for quality dividend stock ideas. Ray Dalio, founder of Bridgewater Associates, has a stellar reputation for spotting promising investments
New Study from Humana Healthcare Research and Harvard University Reveals Better Access to Primary Care for Seniors Receiving Care from Senior-Focused Primary Care Organizations
Humana Inc. (NYSE: HUM), one of the nation’s leading health and well-being companies, recently published a study on senior-focused primary care — a value-based care model that tailors the
AEVIS VICTORIA SA (AEVS.SW) – Klinik Pyramide to be integrated into Privatklinik Bethanien in Zurich